Late last week Californians learned that the number of vaccine
doses coming to the state would decline by at least 33 percent.
On the heels of that news, it was announced today that California
will temporarily halt the administration of the Johnson and
Johnson single-dose vaccine due to concerns about blood clots in
a tiny percentage of recipients.
The state asked local health jurisdictions to immediately pause
the distribution of all Johnson and Johnson vaccines while the
CDC and FDA review the safety of the formula. According to the
CDC, of the over 6.8 million doses administered nationally, there
have been six reported cases of a rare and severe type of blood
clot with symptoms occurring six to 13 days after
vaccination.
In California, nearly 900,000 doses of the Johnson and Johnson
vaccine have been administered and providers report having about
a million doses on hand. California had received more than
570,000 doses from the manufacturer last week but was expected
far fewer doses this week, about 67,000. Any doses now must be
held pending further federal guidance.
